Polypharmacy in the treatment of people diagnosed with borderline personality disorder: repeated cross-sectional study using New Zealand's national databases.

Matthew TennantChris FramptonRoger T Mulder Ben Beaglehole

Published in: BJPsych open (2023)

There is a large burden of psychotropic polypharmacy in people with borderline personality disorder. This is concerning because of the lack of evidence regarding the efficacy of these medications in this group.

Keyphrases

borderline personality disorder
quality improvement
adverse drug
big data
artificial intelligence
deep learning